UBS AM’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.7M | Buy |
30,727
+219
| +0.7% | +$11.8K | ﹤0.01% | 2116 |
|
|
2025
Q4 | $1.48M | Sell |
30,508
-2,763
| -8% | -$108K | ﹤0.01% | 1996 |
|
|
2025
Q3 | $1.02M | Sell |
33,271
-16,534
| -33% | -$379K | ﹤0.01% | 2004 |
|
|
2025
Q2 | $1.11M | Buy |
49,805
+14,892
| +43% | +$312K | ﹤0.01% | 2366 |
|
|
2025
Q1 | $649K | Buy |
34,913
+5,434
| +18% | +$90.7K | ﹤0.01% | 2441 |
|
|
2024
Q4 | $390K | Sell |
29,479
-3,405
| -10% | -$82.5K | ﹤0.01% | 2587 |
|
|
2024
Q3 | $1.1M | Buy |
32,884
+3,223
| +11% | +$110K | ﹤0.01% | 2355 |
|
|
2024
Q2 | $743K | Buy |
29,661
+12,740
| +75% | +$297K | ﹤0.01% | 2506 |
|
|
2024
Q1 | $381K | Hold |
16,921
| – | – | ﹤0.01% | 2351 |
|
|
2023
Q4 | $362K | Hold |
16,921
| – | – | ﹤0.01% | 2388 |
|
|
2023
Q3 | $304K | Hold |
16,921
| – | – | ﹤0.01% | 2433 |
|
|
2023
Q2 | $368K | Hold |
16,921
| – | – | ﹤0.01% | 2413 |
|
|
2023
Q1 | $368K | Buy |
+16,921
| New | +$411K | ﹤0.01% | 2413 |
|
|
2022
Q4 | – | Sell |
-23,007
| Closed | -$587K | – | 2560 |
|
|
2022
Q3 | $587K | Buy |
23,007
+8,361
| +57% | +$196K | ﹤0.01% | 2274 |
|
|
2022
Q2 | $297K | Sell |
14,646
-8,361
| -36% | -$185K | ﹤0.01% | 2482 |
|
|
2022
Q1 | $569K | Hold |
23,007
| – | – | ﹤0.01% | 2421 |
|
|
2021
Q4 | $799K | Sell |
23,007
-1,307
| -5% | -$41.4K | ﹤0.01% | 2328 |
|
|
2021
Q3 | $659K | Hold |
24,314
| – | – | ﹤0.01% | 2369 |
|
|
2021
Q2 | $630K | Buy |
24,314
+9,668
| +66% | +$232K | ﹤0.01% | 2443 |
|
|
2021
Q1 | $316K | Sell |
14,646
-2,227
| -13% | -$56.2K | ﹤0.01% | 2479 |
|
|
2020
Q4 | $363K | Hold |
16,873
| – | – | ﹤0.01% | 2382 |
|
|
2020
Q3 | $249K | Hold |
16,873
| – | – | ﹤0.01% | 2347 |
|
|
2020
Q2 | $377K | Buy |
16,873
+2,524
| +18% | +$46.1K | ﹤0.01% | 2223 |
|
|
2020
Q1 | $203K | Buy |
+14,349
| New | +$218K | ﹤0.01% | 2275 |
|
|
2019
Q4 | – | Sell |
-99,518
| Closed | -$3.48M | – | 2542 |
|
|
2019
Q3 | $3.48M | Sell |
99,518
-2,516
| -2% | -$120K | ﹤0.01% | 1355 |
|
|
2019
Q2 | $5.76M | Buy |
102,034
+4,164
| +4% | +$300K | ﹤0.01% | 1154 |
|
|
2019
Q1 | $7.15M | Buy |
97,870
+3,935
| +4% | +$272K | 0.01% | 1031 |
|
|
2018
Q4 | $5.99M | Sell |
93,935
-9,813
| -9% | -$730K | 0.01% | 1022 |
|
|
2018
Q3 | $10.4M | Buy |
103,748
+10,098
| +11% | +$838K | 0.01% | 928 |
|
|
2018
Q2 | $6.65M | Buy |
93,650
+22,193
| +31% | +$1.86M | 0.01% | 1057 |
|
|
2018
Q1 | $7.44M | Buy |
71,457
+83
| +0.1% | +$9.35K | 0.01% | 1009 |
|
|
2017
Q4 | $7.19M | Buy |
+71,374
| New | +$5.25M | 0.01% | 996 |
|
Other funds holding ANAB
EC
TCM
AAA
VCM
PAI
6CM
